Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multi-disciplinary Pain Intervention (MUD-PI) for Patients With Chronic Widespread Primary Pain (MUD-PI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03413501
Recruitment Status : Unknown
Verified January 2018 by Lars-Petter Granan, Oslo University Hospital.
Recruitment status was:  Active, not recruiting
First Posted : January 29, 2018
Last Update Posted : January 29, 2018
Sponsor:
Information provided by (Responsible Party):
Lars-Petter Granan, Oslo University Hospital

Brief Summary:
Patients who fulfilled inclusion criteria and consented to participate received either treatment as usual at the clinic, or were enrolled in a group-therapy based intervention, the multi-disciplinary pain intervention, led by a Medical doctor, physiotherapist and psychologist at the clinic.

Condition or disease Intervention/treatment Phase
Chronic Pain, Widespread Behavioral: MUD-PI Not Applicable

Detailed Description:

The Department of Pain Management and Research at Oslo University Hospital is Norway's largest outpatient pain clinic. It treats around one thousand new patients annually suffering from chronic pain of all aetiologies. Many of the patients receive interdisciplinary care based on a biopsychosocial framework, by at least two health care providers (physician, physiotherapist, psychologist, occupational therapist and/or nurse).

Participants were recruited through referrals from primary or secondary care, which were identified by an established interdisciplinary team. Patients found potentially eligible for the study were contacted by the research team and consulted with a research physician. Patients who fulfilled the inclusion criteria were invited to participate in the study and signed a consent form. Patients who declined to participate and non-eligible patients received usual care.

Inclusion criteria were 1) age 18 or more; 2) pain in at least three out of five bodily regions (defined as the four quadrants and axially); 3) pain persisting three months or more; 4) the patient was able to give informed consent and benefit from group therapy (including sufficient cognitive capacity and language skills); 5) no other medical condition could better explain the symptoms.

Subjects were randomised either to treatment as usual or a group-based multidisciplinary pain intervention (the MUD-PI).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 49 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Multi-disciplinary Pain Intervention (MUD-PI) for Patients With Chronic Widespread Primary Pain
Actual Study Start Date : September 20, 2016
Estimated Primary Completion Date : February 20, 2018
Estimated Study Completion Date : February 20, 2018

Arm Intervention/treatment
No Intervention: Treatment as usual
Receives treatment as usual at the clinic
Experimental: MUD-PI
Receives multi-disciplinary pain intervention, agroup-based, multi-disciplinary treatment
Behavioral: MUD-PI



Primary Outcome Measures :
  1. Change in Patient generated index [ Time Frame: Change in score on inclusion and 1 week after completion of intervention or control group ]
    Individualised patient reported outcome


Secondary Outcome Measures :
  1. Change in EQ-5D [ Time Frame: Change in score on inclusion and 1 week after completion of intervention or control group ]
    standardised patient reported outcome

  2. Change in Oswestry disability index [ Time Frame: Change in score on inclusion and 1 week after completion of intervention or control group ]
    standardised patient reported outcome



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 18 or more
  • Pain in at least three out of five bodily regions (defined as the four quadrants and axially)
  • Pain persisting three months or more
  • The patient was able to give informed consent and benefit from group therapy (including sufficient cognitive capacity and language skills
  • No other medical condition could better explain the symptoms.
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Lars-Petter Granan, Principal investigator, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT03413501    
Other Study ID Numbers: OsloUH Smerteklinikken
First Posted: January 29, 2018    Key Record Dates
Last Update Posted: January 29, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Pain
Pain
Neurologic Manifestations